EP2270008
8-Heteróarýl-3-alkýl-1,3-díhýdró-imídasó[4,5-c]kínólín-2-ón sem Pl-3 kínasahindrar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
18.5.2006EP published:
3.10.2012EP application number:
10175375.4
EP translation filed:
27.12.2012Grant published:
15.1.2013EPO information:
European Patent Register
Max expiry date:
17.5.2026Expiry date:
17.5.2017
Title:
8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as PI-3 kinases inhibitors
Timeline
Today
18.5.2006EP application
3.10.2012EP Publication
27.12.2012Translation submitted
15.1.2013Registration published
17.5.2017Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Garcia-Echeverria, CarlosAddress:
Basel, CH
Name:
Stauffer, FrédéricAddress:
Reinach, CH
Name:
Furet, PascalAddress:
Thann, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0510390Date:
20.5.2005Country:
GB
Classification
Categories:
C07D 471/04, A61K 31/4188, A61P 35/00, A61P 29/00, A61P 11/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.4.2013
Expires: 17.5.2014
Payer: Árnason Faktor
Number: 9
Paid: 9.4.2014
Expires: 17.5.2015
Payer: Árnason Faktor
Number: 10
Paid: 9.4.2015
Expires: 17.5.2016
Payer: Árnason Faktor
Number: 11
Paid: 12.4.2016
Expires: 17.5.2017
Payer: Árnason Faktor